CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

14 Feb 2025 09:45:21 By NetDania Notify

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025

14 Feb 2025 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 Feb 2025 09:45:13 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

11 Feb 2025 11:15:22 By NetDania Notify

Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU

11 Feb 2025 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 Feb 2025 09:45:04 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

29 Jan 2025 14:22:37 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

28 Jan 2025 12:08:45 By NetDania Notify

Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference

28 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

27 Jan 2025 11:55:04 By NetDania Notify

Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025

08 Jan 2025 08:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 08:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors

09 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

03 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference

21 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

12 Nov 2024 08:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update

07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024

04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference

29 Oct 2024 08:00:01 By Nasdaq GlobeNewswire

Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)

16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire